← FDA Drug Approvals (Drugs@FDA)

ORPHENGESIC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GALT PHARMS · Approved 1998-05-29

Drug application

FDA Application #

ANDA075141

Application type

Abbreviated New Drug Application (Generic)

Brand name

ORPHENGESIC

Generic name

ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE

Active ingredients

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GALT PHARMS

Manufacturer

Galt Pharmaceuticals, LLC

First approval

1998-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown